8 studies found for:    suvorexant
Show Display Options
RSS Create an RSS feed from your search for:
suvorexant
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant High Dose (HD);   Drug: Suvorexant Low Dose (LD);   Drug: Comparator: Placebo
2 Completed
Has Results
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant High Dose (HD);   Drug: Suvorexant Low Dose (LD);   Drug: Comparator: Placebo
3 Completed
Has Results
Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)
Conditions: Insomnia;   Hepatic Insufficiency
Intervention: Drug: Suvorexant
4 Completed
Has Results
Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
Condition: Insomnia
Intervention: Drug: Suvorexant
5 Completed
Has Results
Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032 AM3)
Condition: Insomnia
Interventions: Drug: suvorexant;   Drug: Placebo
6 Completed
Has Results
A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)
Condition: Insomnia
Interventions: Drug: Suvorexant;   Drug: Dose-matched Placebo to Suvorexant
7 Completed
Has Results
Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036 AM1)
Condition: Sleep Apnea
Interventions: Drug: Suvorexant;   Drug: Matching Placebo
8 Completed Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant;   Drug: Dose-matched Placebo to Suvorexant

Indicates status has not been verified in more than two years